Fresenius Medical price target raised to EUR 41.50 from EUR 37.30 at JPMorgan

JPMorgan raised the firm’s price target on Fresenius Medical (FMS) to EUR 41.50 from EUR 37.30 and keeps an Underweight rating on the shares.